15 / 60
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 32, No 2, March/April 2021
AFRICA
69
Trust the
!
Original
S3 ISMO-20 R/7.1.4/136. Isosorbide-5-mononitrate 20 mg/tablet.
For full prescribing information, please refer to package insert.
Pharmaco Distribution (Pty) Ltd. 3 Sandown Valley Crescent, South Tower, 1st Floor, Sandton, 2196; PO Box 786522, Sandton, 2146, South Africa. Tel: + 27 11 784 0077.
Website:
www.pharmaco.co.za1
Long-term prophylaxis and management of
Angina Pectoris
2,3
=
100%
bioavailability
No first-pass metabolism
4
Twice daily
dosage regimen shown
to avoid withdrawal and tolerance
References: 1.
South African approved ISMO package insert.
2.
Ismo 20 Product Monograph (2015).
3.
Abshagen, U., 1992. Pharmacokinetics of isosorbide mononitrate.
The American Journal of Cardiology,
[online] 70(17), pp.G61-G66.
4.
Thadani U, Maranda CR, Amsterdam E, et al. Lack of Pharmacological Tolerance and Rebound
Angina Pectoris during Twice-daily Therapy with Isosorbide-5-Mononitrate.
Annals of Internal Medicine.
1994; 120:353-359. IS_0120.
23. Lancellotti P, Moura L, Pierard LA,
et al
. European Association of
Echocardiography recommendations for the assessment of valvular regurgi-
tation. Part 2: mitral and tricuspid regurgitation (native valve disease
). Eur J
Echocardiogr
2010;
11
: 307–332.
24. Zoghbi WA, Enriquez-Sarano M, Foster E,
et al
. Recommendations for eval-
uation of the severity of native valvular regurgitation with two-dimensional
and Doppler echocardiography
. J Am Soc Echocardiogr
2003; 777–802.
25. Cilliers AM. Rheumatic fever and rheumatic heart disease in Gauteng on
the decline: Experience at Chris Hani Baragwanath Hospital, Johannesburg,
South Africa.
S Afr Med J
2014;
104
(9): 632–634.
26. Statistics SouthAfrica, 2014. Available on line at:
http://ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=click%20
on%20image%20to20zoom&p=pMC3&id=3342091_1750-1172-7-16-1.
jpg
27. Armstrong P, Lekezwa B, Siebrits K. Poverty in South Africa: A profile
based on recent household surveys.2008: Available on line at: https://
ideas.repec.org/p/sza/wpaper/wpapers52.html”>Working Papers</A>
04/2008, Stellenbosch University, Department of Economics. (Accessed
on 04 July 2018).
28. Smit FE, Botes L, Rossouw S,
et al
. The prevalence of rheumatic
heart disease among Grade 10–12 learners in the Free State and
Northern Cape – Preliminary results of the Wheels-of-Hope Outreach
Programme.
SA Heart J
2015;
12
(3): 146–151.
29. Karthikeyan G, Zühlke L, Engel M,
et al
. Rationale and design of a
Global Rheumatic Heart Disease Registry: The REMEDY study.
Am
heart J
2012: 1–6.
30. Manyemba J, Mayosi BM. Intramuscular penicillin is more effective
than oral penicillin in secondary prevention of rheumatic fever – a
systematic review.
S Afr Med J
2003;
93
: 212–218.
31. Robertson KA, Volmink JA, Mayosi BM. Antibiotics for the primary
prevention of acute rheumatic fever: a meta-analysis.
BMC Cardiovasc
Discord
2005;
5
(1): 11.
32. Majeed HA, Yousof AM, Khuffash FA,
et al
. The natural history of
acute rheumatic fever in Kuwait: a prospective six year follow-up report
.
J Chronic Dis
1986;
39
(5): 361–369.
33. Baumgartner H, Falk V, Bax JJ,
et al
. 2017 ESC/EACTS guidelines
for the management of valvulat heart disease.
Eur Heart J
2017;
38
:
2739–2786.